Combishield

Combishield is a dietary supplement developed by Libytec Pharmaceutical, primarily marketed in Greece. It features a synergistic combination of Vitamin D3 (cholecalciferol), Vitamin K2 (menaquinone-7), and Magnesium. The product is designed to support musculoskeletal health and calcium homeostasis. Vitamin D3 facilitates the intestinal absorption of calcium and phosphorus, while Vitamin K2 activates osteocalcin, a protein that binds calcium to the bone matrix, and inhibits the calcification of blood vessels. Magnesium serves as a critical cofactor for over 300 enzymatic reactions, including those required for Vitamin D activation and bone mineralization. It is typically indicated for individuals seeking to maintain bone density and support immune function.

Brand names

Combishield

Other names

cholecalciferol + menaquinone-7 + magnesium